TPBG
TPBG 분자 정보
| 영어 이름 | Trophoblast glycoprotein | 시판 약물 수 | 0 |
| 임상 약물 수 | 16 | 표적 별명 | Trophoblast glycoprotein，5T4 oncotrophoblast glycoprotein，5T4，TPBG，5T4 oncofetal antigen，M6P1，5T4 oncofetal trophoblast glycoprotein，Wnt-Activated Inhibitory Factor 1，WAIF1，5T4AG，5T4-AG |
| 최고 연구 개발 단계 | Phase 2 Clinical | ||
| 영어 이름 | Trophoblast glycoprotein |
| 표적 별명 | Trophoblast glycoprotein，5T4 oncotrophoblast glycoprotein，5T4，TPBG，5T4 oncofetal antigen，M6P1，5T4 oncofetal trophoblast glycoprotein，Wnt-Activated Inhibitory Factor 1，WAIF1，5T4AG，5T4-AG |
| 시판 약물 수 | 0 |
| 임상 약물 수 | 16 |
| 최고 연구 개발 단계 | Phase 2 Clinical |
TPBG 제품 목록
- 속성
Protein (10)Cell (1)Antibody (1)
- 제품 라이브러리
온라인 (12)
- 종
Human (6)Cynomolgus / Rhesus macaque (2)Mouse (2)Rat (1)Rabbit (1)
- 태그
His Tag & Avi Tag (3)Fc Tag (2)His Tag (4)Fc Tag & Avi Tag (1)- (2)
- 마커
Biotin-labeled (3)Unconjugated (8)- (1)
| 제품 번호 | 종 | 발현 시스템 | 제품 설명 | 단백질 구조 | 순도 | 특성 |
|---|---|---|---|---|---|---|
HOT TPG-H52E5 |  Human | HEK293 | Unconjugated Human TPBG / 5T4 Protein, His,AviTag, low endotoxin™ (MALS verified) |  |  |  |
HOT TPG-H82Eb | Human | HEK293 | Biotinylated Human TPBG / 5T4 Protein, His,Avitag™ |  | | |
HOT TPG-M52H3 |  Mouse | HEK293 | Mouse TPBG / 5T4 Protein, His Tag (MALS verified) |  | | |
HOT TPG-C52H3 |  Cynomolgus / Rhesus macaque | HEK293 | Cynomolgus / Rhesus macaque TPBG / 5T4 Protein, His Tag |  | | |
| Human | HEK293 | HEK293/Human TPBG Stable Cell Line |  | |||
| Human | HEK293 | Human TPBG / 5T4 Protein, Fc Tag (MALS verified) |  | | | |
| Human | HEK293 | Human TPBG / 5T4 Protein, His Tag (MALS verified) |  | | | |
| Human | HEK293 | Biotinylated Human TPBG / 5T4 protein, Fc,Avitag™ (MALS verified) |  | | | |
| Mouse | HEK293 | Mouse TPBG / 5T4 Protein, Fc Tag (MALS verified) |  | | ||
 Rabbit | - | Recombinant Monoclonal Anti-TPBG Antibody, Rabbit (P1B10) |
총 수량12
- 1
- 2
TPBG분자 별명
TPBG,5T4,M6P1,5T4AG,WAIF1,5T4 oncofetal antigen,Trophoblast glycoprotein,5T4 oncofetal trophoblast glycoprotein
항체 프로젝트 거래 플랫폼
| 프로젝트 이름 | 프로젝트 단계 | 분자 유형 | 분자 출처 | 질병 영역 | 적응증 |
|---|---|---|---|---|---|
| 5T4 mAb - 01 | Lead | Monoclonal | Humanized Mouse | Solid Tumor | Ovarian cancer,Lung cancer |
임상 약물 정보
| 영어 이름 | 연구 코드 | 연구 개발 단계 | 회사 | 적응증 | 임상 시험 |
|---|---|---|---|---|---|
| Naptumomab estafenatox | TTS-CD3; ABR-217620 | Phase 2 Clinical | Active Biotech Ab | Breast Neoplasms; Carcinoma; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Carcinoma, Transitional Cell; Colorectal Neoplasms; Endometrial Neoplasms; Esophageal Neoplasms; Melanoma; Mesothelioma; Ovarian Neoplasms; Pancreatic Neoplasms; Prostatic Neoplasms; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Triple Negative Breast Neoplasms; Urinary Bladder Neoplasms; Uterine Cervical Neoplasms | 상세 |
| ALG.APV-527 | ALG.APV 527; ADC-1016; ATOR-1016; ALG.APV-527; ALG-APV-527 | Phase 2 Clinical | Alligator Bioscience Ab, Aptevo Therapeutics Inc | Neoplasms; Solid tumours | 상세 |
| JK-06 | JK-06 | Phase 2 Clinical | Xinlitai (Chengdu) Biological Technology Co Ltd | Neoplasms; Solid tumours | 상세 |
| TUB-030 | TUB-030 | Phase 2 Clinical | Tubulis GmbH | Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Small Cell Lung Carcinoma; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Triple Negative Breast Neoplasms | 상세 |
| ACR-246 | ACR246; ACR-246; ADC2154; ADC-2154 | Phase 2 Clinical | Hangzhou Adcoris Biopharmacy Co Ltd | Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Colorectal Neoplasms; Esophageal Neoplasms; Ovarian Neoplasms; Pancreatic Neoplasms; Prostatic Neoplasms; Solid tumours; Uterine Cervical Neoplasms | 상세 |
| IBR-854 | IBR854; IBR-854 | Phase 2 Clinical | Imbioray (Hangzhou) Biomedicine Co Ltd | Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Solid tumours | 상세 |
| SYD-1875 | SYD-1875 | Phase 1 Clinical | Synthon Bv | Solid tumours | 상세 |
| ASN-004 | ASN-004 | Phase 1 Clinical | Asana Biosciences Llc | Solid tumours | 상세 |
| anti-5T4 CAR NK-cell therapy (Wuxi Peapole's Hospital/Hangzhou Yingbairui Biomedical Technology) | Phase 1 Clinical | Imbioray (Hangzhou) Biomedicine Co Ltd | Solid tumours | 상세 | |
| Naptumomab estafenatox/Durvalumab | NTX-352 | Phase 1 Clinical | Neotx Therapeutics Ltd | Solid tumours | 상세 |
| XB-010 | XB-010 | Phase 1 Clinical | Exelixis Inc | Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Esophageal Squamous Cell Carcinoma; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Triple Negative Breast Neoplasms | 상세 |
| FTL-008.16 | FTL-008.16; FTL008.16 | Phase 1 Clinical | Sound(Chengdu)Biopharmacauticals Co Ltd | Solid tumours | 상세 |
| CBA-1535 | CBA-1535 | Phase 1 Clinical | Chiome Bioscience Inc | Carcinoma, Non-Small-Cell Lung; Mesothelioma; Neoplasms; Small Cell Lung Carcinoma; Solid tumours; Triple Negative Breast Neoplasms | 상세 |
| Anti-5T4 CAR-raNK Cell Therapy | Phase 1 Clinical | Imbioray (Hangzhou) Biomedicine Co Ltd | Solid tumours | 상세 | |
| Prostate cancer vaccine(inactivated viral)(University of Oxford) | Clinical | University Of Oxford | Prostatic Neoplasms | 상세 | |
| 68Ga-NOTA-H006 | Clinical | Huashan Hospital | Solid tumours | 상세 |
- 분자 정보
- 제품 목록
- 임상 약물 정보